Synexus has opened a regional office for Eastern Europe in Poland, reflecting the company’s commitment to the region.

The new 3,000-square-foot office will house a regional team with over a decade of experience delivering clinical trials for Synexus clients in Eastern Europe. The team will be responsible for patient engagement programs as well as the management of Synexus' nine dedicated research centers across Poland, Hungary, Romania, Ukraine and Bulgaria.

“Our success in the region is based on our ability to deliver patients and quality data to our clients in pharma,” said Dr. Radoslaw Janiak, regional managing director. “We have put in place a sophisticated patient engagement program which really improves the patient experience and it is these added-value extras which really pay dividends in terms of client success."

Christophe Berthoux, CEO of Synexus, said, "We have an exceptional team in Eastern Europe who have consistently met the needs of our customers. For example, it is no accident that the Wroclaw site was the first Synexus site to be selected to join Pfizer's INSPIRE site network."

Sites in INSPIRE, which stands for Investigator Networks, Site Partnerships and Infrastructure for Research Excellence, have early access to Pfizer‘s portfolio data and advanced information regarding clinical trials to be sponsored by Pfizer. They are involved in publication in scientific journals, protocol design, advisory boards and the sharing of best practice across the INSPIRE network.

Synexus, which has more than 25 dedicated research centers across Europe and Africa, focuses on clinical trials in cardiovascular, metabolic (diabetes and obesity), bone, respiratory and CNS (dementia and pain).